Scrip ID
PHARMAID
Pharmaids Pharmaceuticals Limited has filed a regulatory disclosure with BSE Limited regarding an upcoming Board of Directors meeting. The meeting is scheduled to be held on Wednesday, August 12, 2026.
The primary agenda of the board meeting is to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026. The company will review both standalone and consolidated financial results.
Regarding trading restrictions, the company confirms that the trading window for dealing in the company's securities has been closed since July 1, 2026, as per their earlier intimation dated June 26, 2026. The trading window will reopen after 48 hours from the declaration of the financial results.
The document was signed by Prasanna Subramanya Bhat, who holds the positions of Company Secretary and Compliance Officer for Pharmaids Pharmaceuticals Limited.